Lloyd Advisory Services LLC. Takes Position in McKesson Corporation $MCK

Lloyd Advisory Services LLC. purchased a new stake in McKesson Corporation (NYSE:MCK) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,405 shares of the company’s stock, valued at approximately $1,152,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. GGM Financials LLC bought a new stake in shares of McKesson in the 3rd quarter valued at about $25,000. State of Wyoming bought a new stake in McKesson during the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. bought a new stake in McKesson during the 3rd quarter worth approximately $31,000. Vermillion & White Wealth Management Group LLC bought a new stake in McKesson during the 3rd quarter worth approximately $33,000. Finally, Board of the Pension Protection Fund bought a new stake in McKesson during the 4th quarter worth approximately $33,000. 85.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other McKesson news, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. This represents a 45.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.08% of the stock is currently owned by company insiders.

McKesson Stock Down 0.2%

NYSE:MCK opened at $765.30 on Friday. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The business has a 50 day moving average price of $838.23 and a two-hundred day moving average price of $855.53. The company has a market cap of $91.99 billion, a P/E ratio of 19.89, a price-to-earnings-growth ratio of 1.14 and a beta of 0.35.

McKesson (NYSE:MCK) last released its quarterly earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The firm had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. During the same quarter in the prior year, the firm posted $10.12 EPS. The business’s revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio is 8.53%.

Wall Street Analysts Forecast Growth

MCK has been the subject of a number of research reports. TD Cowen increased their target price on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Citigroup lowered their target price on McKesson from $975.00 to $945.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Weiss Ratings cut McKesson from a “buy (b+)” rating to a “buy (b)” rating in a research note on Monday. Mizuho increased their target price on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Morgan Stanley reissued an “overweight” rating and set a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $968.87.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.